Clinical response to immunization with Cendehill strain rubella vaccine.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001168:Arthritis / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D003875:Drug Eruptions / Q000453:epidemiology; D004342:Drug Hypersensitivity / Q000453:epidemiology*; D005260:Female; D006261:Headache / Q000453:epidemiology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D008199:Lymphadenitis / Q000453:epidemiology; D009325:Nausea / Q000453:epidemiology; D010919:Placebos; D012130:Respiratory Hypersensitivity / Q000453:epidemiology; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus; D012737:Sex Factors; D013045:Species Specificity; D014765:Viral Vaccines / Q000009:adverse effects*; D014839:Vomiting / Q000453:epidemiology
D000906:Antibodies; D010919:Placebos; D012411:Rubella Vaccine; D014765:Viral Vaccines